CVIA Journal

Cardiovascular Innovations and Applications

GWICC 2019

Stroke Prevention in Atrial Fibrillation: Current Strategies and Recommendations

Stroke Prevention in Atrial Fibrillation: Current Strategies and Recommendations

Authors: Naccarelli, Gerald V.; Caputo, Gregory; Abendroth, Thomas; Faber, Samuel; Sendra-Ferrer, Mauricio; Wolbrette, Deborah; Samii, Soraya; Hussain, Sarah; Gonzalez, Mario

Stroke is the most common complication of atrial fibrillation (AF). Guidelines recommend anticoagulant treatment in patients with CHA2DS2VASc scores of >2. Registry data suggests that almost half of patients who should be on therapeutic anticoagulation for stroke prevention in AF (SPAF) are not. Warfarin and more recently developed agents, the “novel anticoagulants” (NOACs) reduce the risk of embolic strokes. In addition, the NOACs also reduce intracranial hemorrhage (ICH) by over 50% compared to warfarin. Anticoagulation and bridging strategies involving cardioversion, catheter ablation, and invasive/surgical procedures are reviewed. The development of reversal agents for NOACs and the introduction of left atrial appendage occluding devices will evolve the use of newer strategies for preventing stroke in high risk AF patients.

Keywords: anticoagulants; atrial fibrillation; stroke

Document Type: Research Article


Cardiovascular Innovations and Applications is indexed in the ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ and Index Copernicus Databases
EX-Lib-90x50 OCLC-90x50 sherpa
NISC logo Directory of Open Access Journals index-copernicus logo
CVIA Journal © 2015